Description:

ODM derived from http://clinicaltrials.gov/show/NCT00275379

Link:

http://clinicaltrials.gov/show/NCT00275379

  1. 3/6/12 3/6/12 -
  2. 6/7/17 6/7/17 - Martin Dugas
Uploaded on:

June 7, 2017

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Subjects seeking medical treatment for symptoms consistent with IC that have been ongoing for > 9 months or seeking medical treatment for a previous documented diagnosis of IC
Subjects who are not surgically sterile or postmenopausal (amenorrheic > 12 months) must agree and commit to the use of a medically acceptable, highly-effective (i.e. double-barrier or IUD), non-hormonal form of birth control during the study and for 30 days after the last dose of test
Exclusion Criteria
Use of herbal supplements (except for a daily multivitamin/mineral supplement not containing herbal components)
History of cancer (other than resected cutaneous basal or squamous cell carcinoma or in situ cervical cancer) with less than 5 years documentation of a disease-free state
Vaginitis or vaginal infection within 1 month before randomization

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial